Tandem Diabetes Care (TNDM) Other Non-Current Liabilities (2013 - 2026)

Tandem Diabetes Care has reported Other Non-Current Liabilities for 14 years, with the latest figure at $50.4 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 36.01% year-over-year to $50.4 million; the trailing twelve-month figure through Mar 2026 stood at $50.4 million (up 36.01% YoY), and the FY2025 full-year result was $49.7 million, up 53.67% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $50.4 million, up from $49.7 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $52.4 million in Q3 2025, with the low at $17.2 million in Q2 2022.
• Historically, Other Non-Current Liabilities has averaged $32.8 million across 5 years, with a median of $32.2 million in 2024.
• The largest YoY upside for Other Non-Current Liabilities was 19752.59% in 2022 against a maximum downside of 38.28% in 2022.
• Tandem Diabetes Care's Other Non-Current Liabilities stood at $23.9 million in 2022, then jumped by 33.08% to $31.8 million in 2023, then gained by 1.69% to $32.4 million in 2024, then soared by 53.67% to $49.7 million in 2025, then climbed by 1.35% to $50.4 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $50.4 million (Q1 2026), $49.7 million (Q4 2025), and $52.4 million (Q3 2025), per Business Quant data.